Solve M.E. is the proud host and organizer of the annual ME/CFS Advocacy Week. Founded in 2017, this nationwide advocacy effort connects people with ME/CFS, other chronic illnesses, scientists, clinicians and caregivers to share their unique stories with Congress.| Solve ME/CFS Initiative
Because of your persistence, advocacy, and shared determination, Congress is finally starting to listen. This year’s Senate Appropriations bills include some of the strongest support for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome […] The post Senate Appropriations: Big Wins for ME/CFS — Thanks to Your Advocacy appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Dr. Maureen Hanson, a professor of molecular biology and genetics at Cornell University and member of Solve’s Research Advisory Council, specializes in understanding the molecular nature of ME/CFS. ME/CFS has […] The post Extracellular Vesicle Proteins in Men with ME/CFS: Changes Before and After Exercise Correlate with Key Symptoms appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
From the ME/CFS Patient, Advocate, Clinical and Research Community Dear Dr. Unger, On the occasion of your retirement from the Centers for Disease Control and Prevention, we – patients, caregivers, […] The post A Thank You to Dr. Beth Unger from the ME/CFS Community appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Dr. Zack Shan is director of the neuroimaging program at the University of the Sunshine Coast (Australia), where he specializes in developing new ways to visualize how ME/CFS affects brain […] The post Diffusion MRI Shows How ME/CFS Changes Brain White Matter for Distinct Patient Subgroups appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Solve M.E., in partnership with The Brain Inflammation Collaborative (BIC), is excited to announce the launch of the unhide® Solve Together Unified Platform, a digital health tool designed to uncover […] The post Solve M.E. and The Brain Inflammation Collaborative Launch the Unified Platform to Advance Research Across 30+ Chronic Conditions appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
After the pandemic eased (and people practiced less social distancing and masking) came a huge surge in respiratory viral infections among young children, associated with significantly more morbidities. Many children […] The post Do SARS-COV-2 Infections Increase the Risk of Subsequent Respiratory Viral Infections Among Children? An NIH RECOVER Study appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Dr. Lorna Thorpe, a professor of population health at the New York University School of Medicine, and Dr. Richard Moggitt, a professor of biomedical informatics at the Emory University School […] The post NIH RECOVER Study Analyzes Electronic Health Records to Estimate Long Covid Incidence appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
The largest-ever genetic study of ME/CFS has just revealed its first results — and they could change how we understand the disease. DecodeME’s groundbreaking DNA analysis points to both the immune and nervous systems as key players, offering fresh clues to the roots of this complex condition.| Solve ME/CFS Initiative
“Brain perfusion changes in chronic fatigue syndrome before and after exercise challenge”Principal Investigators: Michael Van Elzakker (PhD) and Kenneth Kwong (PhD)Massachusetts General Hospital, Harvard Medical School Home MICHAEL VAN ELZAKKER […]| Solve ME/CFS Initiative
“Extensive characterization of the ME/CFS blood and cerebrospinal fluid microbiome + virome” Principal Investigators: Nikos Kyripides (PhD) and David Paez-Espino (PhD), DOE Joint Genome Institute and the Lawrence Berkeley National […]| Solve ME/CFS Initiative
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
The Severe Myalgic Encephalomyelitis (ME) Day of Understanding and Remembrance was started in 2013 by the 25% ME Group as a response to the death of Sophia Mirza, whose birthday […] The post Severe ME Day 2025: #UnitedForME appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Dr. Candace Feldman is a rheumatologist and assistant professor of medicine at Harvard University. She specializes in collecting and analyzing data to improve health care for disadvantaged communities. Dr. Feldman […] The post Results From the RECOVER-Adult Study: How Social Challenges Affect Risk of Developing Long Covid appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Read our summary of a study by Dr. Akiko Iwasaki and her team that distinguishes groups of people with ME/CFS based on blood-plasma and cerebrospinal fluid proteins.| Solve ME/CFS Initiative
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
From June 23–27, Advocacy Week 2025, over 200 fierce, compassionate advocates came together from all across the country to make sure one thing was clear: ME/CFS, Long Covid, and related conditions will not be ignored.| Solve ME/CFS Initiative
Dr. Rob Wüst published a Solve-funded study in "Trends in Endocrinology & Metabolism" examining how Long Covid and ME/CFS affect muscles and physical functioning.| Solve ME/CFS Initiative
The Solve ME/CFS Initiative (Solve M.E.) is proud to award research funds to Dr. Geraldine Cambridge and Dr. Dana Yelin, two world-class scientists who are finding new ways to treat people with Long Covid and ME/CFS.| Solve ME/CFS Initiative
One of the cornerstones of our annual Advocacy Week program is the EmPOWER M.E. roundtable. Panels of patient advocates, professionals, and scientists share their expertise on topics relevant to the quality of life for people with ME/CFS and Long Covid and their caregivers. This year the EmPOWER M.E. topic is “Pacing: Power In Slowing Down.”| Solve ME/CFS Initiative
The Medical Research for Our Troops Act (H.R. 3906) would restore the full $859 million cut by the fiscal year 2025 Continuing Resolution and fund all 35 CDMRP programs at their FY24 levels, including ME/CFS as a continued topic area. Tell your Representative to sign on as a cosponsor today.| Solve ME/CFS Initiative
“Immunosenescence, Premature Aging of the Immune System in ME/CFS and the Response to Fecal Microbe Transplantation”Principal Investigator: Katharine Seton, PhD Home Katharine Seton, PhD “Immunosenescence, Premature Aging of the Immune […]| Solve ME/CFS Initiative
Solve has selected Simmaron Research as the recipient of our latest ME/CFS Catalyst Award. The funds will be used to accelerate a low-dose rapamycin trial for ME/CFS, Long COVID, and other infection-associated chronic conditions (IACCs). The study advances an FDA-approved drug for reducing key symptoms of ME/CFS and Long Covid, repurposing rapamycin to reduce fatigue, orthostatic intolerance, post-exertional malaise, and sleep issues for a subset of people with ME/CFS.| Solve ME/CFS Initiative
“Autoimmune Signature in ME/CFS”PI: Carmen Scheibenbogen, MDCharité—Universitätsmedizin Berlin in Germany Home CARMEN SCHEIBENBOGEN “Autoimmune Signature in ME/CFS”PI: Carmen Scheibenbogen, MDCharité—Universitätsmedizin Berlin in Germany Immune dysregulation has been regularly described in […]| Solve ME/CFS Initiative
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
Solve M.E. is a non-profit org focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
2022 Solve Ramsay Research Grant winner Catherine Seton recently co-authored a review of cognitive dysfunction in ME/CFS.| Solve ME/CFS Initiative
With a new Congress and administration, we have a unique opportunity to introduce ME/CFS, Long Covid, and associated conditions to new decision-makers and build relationships that will shape the future of research, healthcare, and support for our community. By working together, we can create champions in Washington who will help drive meaningful change. Register today for Solve M.E. Advocacy Week 2025!| Solve ME/CFS Initiative
Solve M.E. invests in innovative scientific studies to address knowledge gaps in ME/CFS, Long Covid and other post-infectious diseases.| Solve ME/CFS Initiative
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
In September, the NIH held a three-day workshop at its campus in Bethesda, Maryland, to discuss the path forward for RECOVER-TLC. In this blog, we’re summarizing Day 1 of the workshop in its entirety.| Solve ME/CFS Initiative
Solve M.E. is a non-profit organization focused on ME/CFS, Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
Solve Together is a new platform that brings extensive advantages to the patient community and researchers.| Solve ME/CFS Initiative
A new study in the Journal of the American Medical Association shows that developing long-term ME/CFS-like symptoms is just as likely after being infected with other agents as it is after being infected with SARS-CoV-2. Furthermore, long-term symptoms after other acute infections are as severe as those after SARS-CoV-2 infection. The study illustrates why we must better manage symptoms for all patients with infection-associated chronic diseases and illuminates more ways Long Covid is like ME/...| Solve ME/CFS Initiative
An appropriations sign-on letter is a formal request signed by multiple members of Congress, usually addressed to the leaders of the Appropriations Committees or Subcommittees, urging them to allocate specific funding for particular programs, projects, or initiatives in the federal budget. Learn more about their impact on advocacy.| Solve ME/CFS Initiative
The Long COVID Research Moonshot Act has been introduced! This landmark legislation addresses the urgent needs of millions of Americans suffering from Long Covid and other infection-associated chronic conditions (IACCs), including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).| Solve ME/CFS Initiative
The Senate Appropriations Committee is about to make some crucial decisions on the FY 2025 Labor-HHS-Education Appropriations bill. This includes funding that could be a game-changer for ME/CFS, Long Covid, and other infection-associated chronic conditions (IACCIs). Let’s make sure our voices are heard and our needs are met!| Solve ME/CFS Initiative
Dr. Bruno Paiva (director of the Myeloma Group at the University of Navarra, Spain) and Mr. Manuel Ruiz-Pablos (research technician, medical student, and patient with CFS) published hundreds of papers on how the immune system relates to important diseases, including ME/CFS and Long Covid. In 2019, Solve M.E. awarded this accomplished pair a Ramsay Research Grant to study deficiencies in the immune systems of patients with ME/CFS. This summer, the researchers published a fascinating paper desc...| Solve ME/CFS Initiative
UniteToFight—a virtual conference on Long Covid and ME/CFS—took place on May 15 and 16, 2024. Organized by five patients with Long Covid and attended by over 10,000 people from all over the world, the conference focused on discussing progress and challenges with Long Covid and ME/CFS research; emphasizing the social impact of these diseases; and sharing ideas about how best to help researchers and patients moving forward. Among the dozens of researchers presenting were these eight experts...| Solve ME/CFS Initiative
We're excited to share the newest edition of our flagship research and advocacy journal, The Chronicle!| Solve ME/CFS Initiative
Dr. Akiko Iwasaki and her team members tested whether autoantibodies in patients with COVID could cause the neurological symptoms of Long Covid.| Solve ME/CFS Initiative
Dr. Deborah Duricka—assistant professor at the University of Alaska—received a Solve M.E. Ramsay grant in 2023 to study whether a procedure called stellate ganglion block (SGB) can help patients with Long Covid. The stellate ganglion is important for automatically controlling certain bodily functions, like heart rate, blood pressure, and sweating. Injecting an anesthetic into the stellate ganglion (the SGB) can help reduce symptoms associated with Long Covid, for example by restoring prop...| Solve ME/CFS Initiative
NASEM's report, "A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences" is an important step in shortening the path to diagnosis, improving medical education about our category of illnesses, and ensuring that data collection can begin to be streamlined - dramatically improving the quality and ease of research in our field.| Solve ME/CFS Initiative
At Solve M.E., our mission is to drive research and advocacy efforts for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long Covid, and other infection-associated chronic conditions and illnesses (IACCIs). This year, we have championed three critical appropriations requests to Congress, aiming to secure funding and resources to advance our cause. Two of our appropriations efforts are specific to ME/CFS. Below, we outline the purposes and significance of each of these efforts.| Solve ME/CFS Initiative
Kaine spoke candidly about his three-year Long Covid journey, and what's needed to make real progress for the millions who suffer.| Solve ME/CFS Initiative
